Target intelligence / Profile preview

RNA, U6 small nuclear 156, pseudogene (RNU6-156P)

Target
RNU6-156P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, U6 small nuclear 156, pseudogene (RNU6-156P) is a non-protein-coding sequence in the human genome classified as a pseudogene. It resembles the sequence of U6 small nuclear RNA (snRNA), which is integral to the spliceosome complex, but has accumulated mutations, truncations, or lacks essential regulatory regions rendering it non-functional[1][2]. As a pseudogene, it does not produce a functional small nuclear RNA or protein and is not involved in canonical snRNA-mediated processes. While some pseudogenes have regulatory roles – such as acting as miRNA sponges in competitive endogenous RNA networks and influencing gene expression – most remain biologically inert, and there is no substantive evidence of RNU6-156P playing a specific role in physiology or disease[1][2][3]. Consequently, it is not considered a therapeutic target, nor is it directly involved in any known drug mechanisms or biomarker profiles.

Other names
RNU6-156PU6 snRNA pseudogene 156
02

Mechanism of action

not applicable (no drugs target RNU6-156P)

03

Biological functions

Possible regulatory roles as non-coding RNA, such as competitive endogenous RNA activity or microRNA sponging (speculative for this specific pseudogene but described for pseudogenes generally)
04

Disease associations

No direct disease association for RNU6-156P; pseudogenes can act as regulators in cancer and other diseases, but evidence is only for some specific pseudogenes

Beyond the preview

Go deeper on RNA, U6 small nuclear 156, pseudogene (RNU6-156P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 156, pseudogene (RNU6-156P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call